Robo.ai Inc.

AIIO · Consumer Cyclical · $1.12
✦ AI ANALYSIS — not investment advice
SELL Low conviction 6-12 months
$0.85target
↘ 23.7% below the current $1.12

AIIO screens as a SELL because the stock still carries a 17.82x P/S multiple despite FY2025 revenue collapsing 92.1%, a current ratio of 0.06, and no verified earnings framework to underwrite the company’s 2026 revenue claims.

Confidence low
◆Investment thesis

The stock remains an avoid even after a 96.8% collapse from the 52-week high, because the operating and balance-sheet facts are still worse than the price implies. FY2025 revenue fell 92.1% YoY to $0.0B, and the company posted a staggering -16,519.8% operating margin with EPS of -$10.59. That is not a temporarily soft year. It is the profile of a business with no visible earnings framework, no demonstrated cost structure, and no margin of safety in the reported financials. At the same time, the stock trades at 17.82x P/S versus a 0.4x peer average, which means investors are paying a premium multiple for a company that, on reported numbers, barely has a functioning income statement.

The one fact that keeps conviction from being high is the company’s own October update: September revenue exceeded $100M and management expects approximately $600M for full-year 2026. If that is real, the stock is no longer being valued on FY2025 at all, it is being valued on an extreme rebound. But that is exactly the problem. The market has only a headline, not audited proof, not an earnings-call walkthrough, not segment detail, and not a beat/miss record that would support giving management the benefit of the doubt. With a current ratio of 0.06, the balance sheet is too tight to accept aggressive growth claims on trust alone.

The case depends on three things, and all three remain unresolved. First, the company has to prove the ~$600M FY2026 revenue figure in filings, not press releases. Second, it has to show that this revenue carries gross profit and can move operating margin meaningfully off -16,519.8%. Third, it has to stabilize funding and working capital, because distressed liquidity can destroy equity value even when orders or projects exist on paper. None of those points is yet confirmed.

Price action does not rescue the thesis. A stock that is -52.54% in one month, -72.48% in three months, and -64.6% below its 200-day average is not merely cheap, it is signaling an ongoing credibility problem. There can be violent rebounds, especially with 10.21% short interest, but that is a trader’s setup, not an investment case. Until hard financial evidence catches up with the 2026 narrative, the equity still looks overpriced at $1.12 relative to the risk of dilution, disappointment, or further business-model instability.

⋔Scenarios · 6-12 months
$0.25bear · 35%
$0.85base · 45%
$2.50bull · 20%
Bull

The company validates ~$600M FY2026 revenue, stabilizes liquidity, and the stock squeezes from a depressed base with 10.21% short interest.

Base

Some revenue recovery materializes, but poor disclosure, negative margins, and balance-sheet strain keep the stock below current levels.

Bear

Liquidity stress deepens, 2026 revenue claims fail to show up in audited results, and the stock trades toward distressed optionality.

⊚Signal check
AISELL
QuantSELL
Analysts—
contrarian

No analyst coverage available to cross-check.

◑Quality & risk
41Quality
57Risk
Quality factors
Profitability50
Valuation50
Cash flow50
Shareholder50
Financial health47
Growth40
Sentiment34
Innovation32
Risk drivers · Moderate
Market29%
Execution26%
Financial23%
Valuation22%
futuregrowth
Never, ever invest in the present.
— Stanley Druckenmiller
→Forward outlook

Forward earnings power is currently unknowable because the company has no credible earnings estimate set, trailing EPS is -$10.59, and there is no basis yet to convert the ~$600M FY2026 revenue statement into sustainable margin or cash flow. The moat looks weak today and still weak 3-5 years out: the recent news flow points to shifting concepts across marine infrastructure, security, and industrial projects rather than a proven scaled software or auto-manufacturing franchise with recurring economics. AI is not yet an advantage here, it is mostly branding until filings show proprietary products, customer adoption, and gross profit. Higher rates, with the 10-year at 5.27%, also matter because a company with a 0.06 current ratio and no visible profits gets very little benefit of the doubt in funding-intensive markets.

⚡Key drivers
Bull case
  • Management stated September 2026 revenue exceeded $100M and expects roughly $600M for FY2026, which, if real and repeatable, would imply a dramatic turnaround from FY2025’s $0.0B base
  • The stock is already -96.8% versus the 52-week high of $34.80 and -64.6% below the 200-day average of $3.17, so much speculative excess has already been washed out
  • P/B is 0.18, which can attract distressed-value buyers if assets or subsidiaries prove monetizable
  • Short interest is 10.21% of float, enough to create sharp rallies around promotional or contract-related news even if fundamentals remain weak
Bear case
  • FY2025 operating margin was -16,519.8%, versus -795.2% the prior year, which points to a business with no demonstrated operating model at current scale
  • EPS was -$10.59 in FY2025 and there is no P/E because the company is loss-making, so the equity cannot be underwritten on earnings power today
  • Top-3 institutional ownership is 0.0% and there is no analyst coverage, leaving little external validation of management’s financial claims
  • Price action remains broken, -52.54% in 1 month and -72.48% in 3 months, which is consistent with collapsing confidence rather than simple volatility
⌗Key metrics
MetricValueContext
Current price$1.12Reference point for valuation and scenario analysis
Price target$0.85Ground-truth target, -23.7% versus current, low confidence
FY2025 revenue$0.0B-92.1% YoY, reported business effectively reset
FY2025 EPS-$10.59Loss-making, 10.3% YoY change
Operating margin-16519.8%Versus -795.2% prior FY, severe deterioration
P/S17.82xVersus 0.4x peer average, rich despite collapse in reported revenue
P/B0.18xDistressed valuation signal, but not enough on its own with weak liquidity
Current ratio0.06Acute near-term liquidity pressure
Quality / Risk41/100 | 57/100Moderate overall risk with weak quality profile
52-week position$0.54 to $34.80Current price is -96.8% versus the high
Short interest10.21%1,275,095 shares, 0.1 days-to-cover, squeezeable but mostly a trading factor
◎How the $0.85 target is built
P/S Multiple · 4% (faded)$0.02
Quality-adjusted · 20%$1.04
Low confidence · sales quality blend blend
⚑Risk & catalyst
Primary risk

The biggest risk to a bearish view is that the company’s stated ~$600M FY2026 revenue outlook proves real, because that would make today’s valuation look far less stretched versus the FY2025 $0.0B base.

Next catalyst

The next catalyst is the company’s next earnings release or audited filing that either substantiates or undermines the claimed September revenue above $100M and FY2026 revenue of about $600M.

⇄Positioning & flows
Short interest0.7% of float · 0.1d to cover · -2.6%

Ownership is very weak. Top-3 institutional ownership is 0.0% and insiders own only 3.8%, which suggests limited sponsorship and limited alignment relative to the scale of the strategic pivot. Short interest at 10.21%, or 1.28M shares, is meaningful enough for squeezes, but 0.1 days-to-cover means the setup is more for trading spikes than a durable positioning squeeze.

▦Segments
Reported FY2025 businessRevenue $0.0B

The company reported an effective collapse in revenue, down 92.1% YoY, so the current segment picture is not meaningfully disclosed in the provided data.

ALIF-related industrial and maritime initiatives

Recent news points to industrial park development, marine security, and oil-spill response concepts, but no audited revenue split is provided.

Geography

No geographic revenue breakout is available in the provided materials.

◈Moat & edge

There is no clear moat in the disclosed numbers. The company has not shown recurring revenue, cost advantage, manufacturing scale, software lock-in, or regulatory exclusivity, and the recent news flow reads more like project incubation than a defensible platform. Without audited proof that the new initiatives convert into durable contracts and positive unit economics, any moat claim is speculative and likely fragile.

⊞Capital allocation

Capital allocation cannot be called disciplined based on the available data because FCF, capex, buybacks, and dividends all round to $0.0B, while the core issue is survival rather than optimization. With a 0.06 current ratio, the priority should be liquidity preservation and transparent funding plans, not expansion narratives. Until filings show real cash generation or a strengthened balance sheet, investors should assume capital allocation is constrained, not strategic.

∎The bottom line

Rated SELL, Low conviction. The stock is not attractive simply because it is down a lot: the reported business shrank to $0.0B revenue, losses remained extreme, and liquidity looks fragile at a 0.06 current ratio. The only credible path to upside is proof that the company’s claimed ~$600M FY2026 revenue is real and profitable, and that proof is not in hand yet. A move to HOLD would require audited confirmation of the rebound plus clear balance-sheet stabilization. A move to BUY would require not just revenue, but visible earnings power and cash generation.

≣ Full research note tap to expand

Executive Summary

SELL, Low conviction. Rated SELL, Low conviction. The stock has already collapsed 96.8% from its 52-week high, but the underlying numbers still do not support the current $1.12 price: FY2025 revenue was effectively $0.0B, operating margin was -16,519.8%, and liquidity looks severely strained with a 0.06 current ratio. The only thing holding the case together is a company update pointing to more than $100M September revenue and about $600M FY2026 revenue, but without earnings-call detail, segment disclosure, or a beat/miss record, that claim is too thin to offset the balance-sheet and credibility risk.

Investment Thesis

The stock remains an avoid even after a 96.8% collapse from the 52-week high, because the operating and balance-sheet facts are still worse than the price implies. FY2025 revenue fell 92.1% YoY to $0.0B, and the company posted a staggering -16,519.8% operating margin with EPS of -$10.59. That is not a temporarily soft year. It is the profile of a business with no visible earnings framework, no demonstrated cost structure, and no margin of safety in the reported financials. At the same time, the stock trades at 17.82x P/S versus a 0.4x peer average, which means investors are paying a premium multiple for a company that, on reported numbers, barely has a functioning income statement.

The one fact that keeps conviction from being high is the company’s own October update: September revenue exceeded $100M and management expects approximately $600M for full-year 2026. If that is real, the stock is no longer being valued on FY2025 at all, it is being valued on an extreme rebound. But that is exactly the problem. The market has only a headline, not audited proof, not an earnings-call walkthrough, not segment detail, and not a beat/miss record that would support giving management the benefit of the doubt. With a current ratio of 0.06, the balance sheet is too tight to accept aggressive growth claims on trust alone.

The case depends on three things, and all three remain unresolved. First, the company has to prove the ~$600M FY2026 revenue figure in filings, not press releases. Second, it has to show that this revenue carries gross profit and can move operating margin meaningfully off -16,519.8%. Third, it has to stabilize funding and working capital, because distressed liquidity can destroy equity value even when orders or projects exist on paper. None of those points is yet confirmed.

Price action does not rescue the thesis. A stock that is -52.54% in one month, -72.48% in three months, and -64.6% below its 200-day average is not merely cheap, it is signaling an ongoing credibility problem. There can be violent rebounds, especially with 10.21% short interest, but that is a trader’s setup, not an investment case. Until hard financial evidence catches up with the 2026 narrative, the equity still looks overpriced at $1.12 relative to the risk of dilution, disappointment, or further business-model instability.

Key Metrics

MetricValueContext
Current price$1.12Reference point for valuation and scenario analysis
Price target$0.85Ground-truth target, -23.7% versus current, low confidence
FY2025 revenue$0.0B-92.1% YoY, reported business effectively reset
FY2025 EPS-$10.59Loss-making, 10.3% YoY change
Operating margin-16519.8%Versus -795.2% prior FY, severe deterioration
P/S17.82xVersus 0.4x peer average, rich despite collapse in reported revenue
P/B0.18xDistressed valuation signal, but not enough on its own with weak liquidity
Current ratio0.06Acute near-term liquidity pressure
Quality / Risk41/10057/100Moderate overall risk with weak quality profile
52-week position$0.54 to $34.80Current price is -96.8% versus the high
Short interest10.21%1,275,095 shares, 0.1 days-to-cover, squeezeable but mostly a trading factor

Financial Strength

Financial strength looks weak. The headline issue is not leverage, because debt data is largely not meaningful here, it is liquidity and business viability: a 0.06 current ratio leaves little room for execution misses, while negative EPS and an absurdly negative operating margin show no proven ability to self-fund. The low 0.18x P/B may look optically cheap, but distressed equities often screen cheap on book value right before more dilution or asset impairment. Until reported revenue, working capital, and margins normalize together, the balance sheet should be viewed as a source of downside, not support.

Competitive Position

There is no clear moat in the disclosed numbers. The company has not shown recurring revenue, cost advantage, manufacturing scale, software lock-in, or regulatory exclusivity, and the recent news flow reads more like project incubation than a defensible platform. Without audited proof that the new initiatives convert into durable contracts and positive unit economics, any moat claim is speculative and likely fragile.

Management & Guidance

Management’s disclosed outlook now hinges on the statement that September 2026 revenue exceeded $100M and that FY2026 revenue should be about $600M. That is a dramatic claim against a FY2025 revenue base of $0.0B, and it would represent a wholesale reset in the business if validated. Credibility is hard to score positively, though, because there is no recent earnings-call analysis available, the earnings track record versus estimates is N/A, and there is no sell-side coverage to pressure-test assumptions. In that context, guidance should be treated as provisional until audited filings show collections, margins, and segment composition.

Segment Analysis

  • Reported FY2025 business (Revenue $0.0B): The company reported an effective collapse in revenue, down 92.1% YoY, so the current segment picture is not meaningfully disclosed in the provided data.
  • ALIF-related industrial and maritime initiatives (Not disclosed): Recent news points to industrial park development, marine security, and oil-spill response concepts, but no audited revenue split is provided.
  • Geography (Not disclosed): No geographic revenue breakout is available in the provided materials.

Capital Allocation

Capital allocation cannot be called disciplined based on the available data because FCF, capex, buybacks, and dividends all round to $0.0B, while the core issue is survival rather than optimization. With a 0.06 current ratio, the priority should be liquidity preservation and transparent funding plans, not expansion narratives. Until filings show real cash generation or a strengthened balance sheet, investors should assume capital allocation is constrained, not strategic.

Positioning & Flows

Ownership is very weak. Top-3 institutional ownership is 0.0% and insiders own only 3.8%, which suggests limited sponsorship and limited alignment relative to the scale of the strategic pivot. Short interest at 10.21%, or 1.28M shares, is meaningful enough for squeezes, but 0.1 days-to-cover means the setup is more for trading spikes than a durable positioning squeeze.

Bull Case

  • Management stated September 2026 revenue exceeded $100M and expects roughly $600M for FY2026, which, if real and repeatable, would imply a dramatic turnaround from FY2025’s $0.0B base
  • The stock is already -96.8% versus the 52-week high of $34.80 and -64.6% below the 200-day average of $3.17, so much speculative excess has already been washed out
  • P/B is 0.18, which can attract distressed-value buyers if assets or subsidiaries prove monetizable
  • Short interest is 10.21% of float, enough to create sharp rallies around promotional or contract-related news even if fundamentals remain weak

Bear Case

  • FY2025 operating margin was -16,519.8%, versus -795.2% the prior year, which points to a business with no demonstrated operating model at current scale
  • EPS was -$10.59 in FY2025 and there is no P/E because the company is loss-making, so the equity cannot be underwritten on earnings power today
  • Top-3 institutional ownership is 0.0% and there is no analyst coverage, leaving little external validation of management’s financial claims
  • Price action remains broken, -52.54% in 1 month and -72.48% in 3 months, which is consistent with collapsing confidence rather than simple volatility

Valuation & Price Target

Engine price target $0.85 (-23.7% vs current), Low confidence.

  • P/S Multiple: $0.02 (4% weight)
  • Quality-adjusted: $1.04 (20% weight)

This aligns with the quant baseline of SELL, though the conviction stays Low because the company’s own update about more than $100M September revenue and roughly $600M FY2026 revenue could change the story quickly if verified. The reason not to upgrade despite that headline is straightforward: the last reported year showed $0.0B revenue, -16,519.8% operating margin, -$10.59 EPS, and a 0.06 current ratio, while the stock still trades at 17.82x sales on stale trailing data versus a 0.4 peer average. There is also no analyst coverage to cross-check management’s turnaround claims, so the burden of proof remains very high.

Risk Assessment

Risk score 57/100 (Moderate). The biggest risk to a bearish view is that the company’s stated ~$600M FY2026 revenue outlook proves real, because that would make today’s valuation look far less stretched versus the FY2025 $0.0B base.

The Bottom Line

Rated SELL, Low conviction. The stock is not attractive simply because it is down a lot: the reported business shrank to $0.0B revenue, losses remained extreme, and liquidity looks fragile at a 0.06 current ratio. The only credible path to upside is proof that the company’s claimed ~$600M FY2026 revenue is real and profitable, and that proof is not in hand yet. A move to HOLD would require audited confirmation of the rebound plus clear balance-sheet stabilization. A move to BUY would require not just revenue, but visible earnings power and cash generation.

Go deeper in the app

Live charts, options analytics, the full earnings-call breakdown, price alerts, and every other stock — updated in real time.

Get Tickr